ABCA4 (ATP-binding cassette transporter A4) is a 2,273-amino acid protein belonging to the ABC transporter family, primarily expressed in photoreceptor cells and retinal pigment epithelium (RPE)[@allikmets1997]. It plays a critical role in visual cycle function and retinal homeostasis, with mutations causing inherited retinal dystrophies affecting millions of people worldwide.
...
ABCA4 Protein (ABCA4)
Path: /proteins/abcac4-protein
Title: ABCA4 Protein (ABCA4)
Tags: section:proteins, kind:protein
ABCA4 (ATP-binding cassette transporter A4) is a 2,273-amino acid protein belonging to the ABC transporter family, primarily expressed in photoreceptor cells and retinal pigment epithelium (RPE)[@allikmets1997]. It plays a critical role in visual cycle function and retinal homeostasis, with mutations causing inherited retinal dystrophies affecting millions of people worldwide.
ABCA4 is a member of the ATP-binding cassette (ABC) transporter family, specifically the A subfamily. Unlike many ABC transporters that are involved in drug efflux and multidrug resistance, ABCA4 has evolved a specialized function in the retina, where it transports retinoid compounds essential for the visual cycle[@weng1999]. The protein is expressed exclusively in photoreceptor outer segments, where it mediates the ATP-dependent transport of N-retinylidene-phosphatidylethanolamine (N-retinylidene-PE) across the disc membrane.
Structure
ABCA4 has the typical ABC transporter architecture, adapted for its specialized role in photoreceptor cells:
Transmembrane Domains
Two transmembrane domains (TMD): 12 transmembrane helices spanning the disc membrane
Extracellular loops: Form the substrate entry site for retinoid compounds
Intracellular loops: Connect TMDs and contain regulatory elements
Nucleotide-Binding Domains
Two nucleotide-binding domains (NBD): ATP-binding cassettes with Walker A/B motifs
ABC signature (C-loop): Contains the conserved LSGGQ motif
H-loop (switch region): Contains the catalytic histidine
Unique Structural Features
N-terminal extracellular domain: Unique to the ABCA subfamily
Coupling helix: Connects TMD to NBD for conformational transmission
Dimerization: The protein forms a functional homodimer in the membrane
Structural Comparison
ABCA4 shares structural features with other ABCA subfamily members:
ABCA1: Cholesterol transporter, implicated in Alzheimer's disease
ABCA2: Brain-expressed, associated with Alzheimer's disease risk
ABCA3: Lung surfactant homeostasis
ABCA4: Retinal-specific visual cycle function
Normal Function
ABCA4 performs essential functions in the visual cycle[@sun2019]:
N-retinylidene-PE Transport
ABCA4 flips N-retinylidene-phosphatidylethanolamine from outer to inner leaflet of disc membranes[@weng1999]. This function is critical because:
All-trans-retinal released from rhodopsin during phototransduction binds to phosphatidylethanolamine (PE) to form N-retinylidene-PE
ABCA4 transports this compound to the inner leaflet where it can be processed
This prevents accumulation of toxic retinoid compounds in the outer segment
Photoreceptor Outer Segment Maintenance
ABCA4 is essential for proper disc shedding and renewal:
Supports daily renewal of ~10% of outer segment
Maintains disc membrane lipid composition
Enables proper rhodopsin localization
Retinal Pigment Epithelium Function
ABCA4 supports RPE function through:
Visual cycle and rhodopsin regeneration
Phagocytosis of photoreceptor outer segments
Prevention of toxic lipofuscin accumulation
Lipid Transport
ABCA4 regulates phosphatidylethanolamine and phosphatidylglycerol distribution:
Maintains membrane asymmetry
Supports lipid rafts for signaling
Prevents lipid peroxidation
Visual Pigment Regeneration
ABCA4 facilitates the recycling of retinaldehyde for rhodopsin regeneration:
All-trans-retinal → 11-cis-retinal conversion
Supports dark adaptation
Enables continuous phototransduction
Role in Neurodegeneration
Stargardt Disease (STGD1)
ABCA4 mutations cause Stargardt disease, the most common inherited retinal dystrophy[@cremers2020]:
Prevalence: 1 in 10,000 individuals
Inheritance: Autosomal recessive
Age of onset: Childhood to adolescence
Pathogenesis
Loss of function leads to accumulation of toxic bisretinoid lipofuscin in the RPE[@radu2008]
A2E and related compounds build up, causing RPE cell death
Progressive central vision loss typically begins in childhood or adolescence
Fundus flavimaculatus represents a variant with later onset
Molecular Mechanisms
Impaired N-retinylidene-PE transport
Increased all-trans-retinal in outer segments
Accelerated lipofuscin formation
RPE cell death and photoreceptor loss
Genotype-Phenotype Correlations
Severe mutations (null alleles): Early-onset, rapid progression
Mild mutations (hypomorphic alleles): Later onset, slower progression
Missense mutations: Variable phenotype depending on residual function
Age-Related Macular Degeneration (AMD)
ABCA4 variants modify AMD risk[@tanna2017]:
ABCA4 polymorphisms associated with increased AMD susceptibility
Compromised RPE function contributes to drusen formation
Oxidative stress in the aging retina interacts with ABCA4 variants
Geographic atrophy progression linked to ABCA4-mediated pathways
Relationship to Stargardt and AMD
Some ABCA4 variants cause Stargardt disease in homozygotes
Same variants may increase AMD risk in heterozygotes
Shared mechanism of lipofuscin accumulation
Retinitis Pigmentosa
ABCA4 mutations can cause retinal degeneration:
Progressive photoreceptor cell death leading to tunnel vision
Rod-cone degeneration with rod dysfunction preceding cone loss
Night blindness as an early symptom
Potential Neurological Connections
While ABCA4 is primarily a retinal protein, emerging evidence suggests potential CNS connections:
ABCA4 expression in some brain regions
Possible role in vitamin A metabolism
Connections to neurodegenerative disease pathways
Therapeutic Targeting
Gene Therapy
ABCA4 gene therapy is a major focus of current research[@schmitt2020]:
AAV vectors being engineered for ABCA4 delivery to photoreceptors
CRISPR-Cas9 approaches to correct specific mutations
Prime editing for precise corrections
Challenges include the large gene size (6.8 kb coding sequence)
Clinical Trials
Several trials in earlier stages for ABCA4
Lessons learned from voretigene neparvovec-rzyl (Luxturna) for RPE65 being applied